Author:
Gade Lalitha,Muñoz Jose F.,Sheth Mili,Wagner Darlene,Berkow Elizabeth L.,Forsberg Kaitlin,Jackson Brendan R.,Ramos-Castro Ruben,Escandón Patricia,Dolande Maribel,Ben-Ami Ronen,Espinosa-Bode Andrés,Caceres Diego H.,Lockhart Shawn R.,Cuomo Christina A.,Litvintseva Anastasia P.
Funder
Division of Intramural Research, National Institute of Allergy and Infectious Diseases
Subject
Genetics (clinical),Genetics,Molecular Medicine
Reference25 articles.
1. Isolation of Candida auris from 9 patients in Central America: importance of accurate diagnosis and susceptibility testing;Araúz;Mycoses,2018
2. Multidrug-resistant Candida: epidemiology, molecular mechanisms, and treatment;Arendrup;J. Infect. Dis.,2017
3. Multidrug-resistant Candida haemulonii and C. auris, Tel Aviv, Israel;Ben-Ami;Emerg. Infect. Dis,2017
4. Fluconazole resistance in Candida species: a current perspective;Berkow;Infect. Drug Resist,2017
5. Reclassification of the Candida haemulonii complex as Candida haemulonii (C. haemulonii group I), C. duobushaemulonii sp. nov. (C. haemulonii group II), and C. haemulonii var. vulnera var. nov.: three multiresistant human pathogenic yeasts;Cendejas-Bueno;J. Clin. Microbiol,2012